Skip to main content

Lindsey James, Steve Headey (Monash University, Australia), Ken Pearce and Stephen Frye have been awarded a grant by the PharmAlliance Research Working Group and Deans to assist in funding preliminary data for the project “Discovery of Inhibitors for the Methyl-Lysine Reader Protein, 53BP1, Using Fragment-Based Screening.”

PharmAlliance describes the collaborative efforts and partnering of The University of North Carolina at Chapel Hill, Monash University, and University College London “to advance and transform research, education, and practice in pharmacy and the pharmaceutical sciences”. (Jan. 2016)

Comments are closed.